A consultation with our medical team is required to determine if this therapy is appropriate for you.
IV therapy bypasses digestive processes allowing nutrients to reach the cells more quickly than with oral supplementation making it a great alternative for patients with weakened digestion, autoimmune disorders, and low immunity
Qualified researchers can review current lot data on the BPC-157 product page, browse the full research peptide catalog, or compare suppliers more broadly in the guide to the top peptide companies in the USA
Free Ship Offer Free Delivery Over $500* $100 - $249 * for a $50 delivery fee $250 - $499* for a $25 delivery fee Valid within our delivery area
Approximately 39% of adults over 18 have experienced back pain in the past three months, and many of those cases may be influenced by psychological stress rather than physical injury
Soon after WADA took action, the FDA added BPC-157 to the so-called Category 2 Bulk Substance List, which designates it as not eligible for compounding for human use